epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Elidel
    pimecrolimus topical
  • remove Inzirqo
    hydrochlorothiazide
  • remove Paxlovid
    nirmatrelvir and ritonavir

multicheck MultiCheck Results - 1 Interaction

Smiley face Smiley face

Caution Advised

Smiley face Smiley face Elidel (pimecrolimus topical) + Paxlovid (nirmatrelvir and ritonavir)

Caution Advised


pimecrolimus topical + ritonavir

caution advised: combo may incr. pimecrolimus levels, risk of serious infection, other adverse effects (hepatic metabolism possibly inhibited)

Additional Considerations

Smiley face Smiley face nirmatrelvir in Paxlovid

patients on ritonavir- or cobicistat-containing HIV or HCV regimens may continue their tx as indicated

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information